StockClub

GTBP

GTBPGT Biopharma, Inc.$ --
GT Biopharma, Inc.

GT Biopharma, Inc.

GTBP

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
0M USD
YoY -
Operating Income
-6M USD
YoY -48.7%
Net Income
-23M USD
YoY -510.1%
EPS
-4.97$
YoY -149.7%

Revenue

$0
FY2024 Q1$0
$0
Q1
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
Actual
$0 (-)

Net Income

$-28.4M
FY2024 Q1$-2.3M
$-2.3M
Q1
FY2024 Q2$-6M
$-6M
Q2
FY2024 Q3$-9.4M
$-9.4M
Q3
FY2024 Q4$-13.2M
$-13.2M
Q4
FY2025 Q1$-776,000
$-776,000
Q1
FY2025 Q2$-2.2M
$-2.2M
Q2
FY2025 Q3$-5.3M
$-5.3M
Q3
FY2025 Q4$-28.4M
$-28.4M
Q4
Actual
$-15.2M (-115.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$0
FY2021
$0
FY2022
Actual:$0
FY2022
$0
FY2023
Actual:$0
FY2023
$0
FY2024MISS
Actual:$0
Est:$13M
FY2024MISS
$0
FY2025MISS
Actual:$0
Est:$13.5M
FY2025MISS
$0

Analyst Estimates